•
China-based Bloomage Biotech (SHA: 688363) has revealed that a termination agreement has been signed with South Korea-headquartered Medytox Inc., and its subsidiary Bloomage Cayman, along with the joint venture (JV) Medybloom Ltd. This termination signifies the cancellation of two key agreements. Cancellation of Joint Venture and Sole Agency AgreementsThe first…